Hosted on MSN12h
HC Wainwright & Co. Initiates Coverage of CRISPR Therapeutics (CRSP) with Buy Recommendation
Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
H.C. Wainwright Raises BlackSky Technology Inc. (BKSY) Price Target to $20, Maintains ‘Buy’ Amid Strong Contract Growth
We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...
bovnews15h
The BBAI Conundrum: Why BigBear.ai Holdings Inc’s Stock Is Making Headlines Again
H.C. Wainwright has recently reiterated BigBear.ai Holdings Inc (BBAI) stock to Buy rating, as announced on December 30, 2024, according to Finviz. Earlier, on January 9, 2024, Cantor Fitzgerald had ...
Knightscope, Inc. (KSCP) Receives ‘Buy’ Rating from H.C. Wainwright with $16 Target
We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...
Crispr Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Mitchell Kapoor initiated coverage of Crispr Therapeutics (CRSP) with a Buy rating and $65 price target The firm says ...
Xoma price target lowered to $104 from $123 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Xoma (XOMA) to $104 from $123 and keeps a Buy rating on the shares. The firm removed ...
HC Wainwright Has Strong Estimate for PepGen FY2025 Earnings
Equities researchers at HC Wainwright boosted their FY2025 earnings per share (EPS) estimates for PepGen in a research report issued to clients and investors on Thursday, January 30th. HC Wainwright ...
HC Wainwright Comments on Knightscope FY2024 Earnings
Equities research analysts at HC Wainwright issued their FY2024 EPS estimates for shares of Knightscope in a research report issued to clients and investors on Thursday, January 30th. HC Wainwright ...
TMCnet3d
H.C. Wainwright Initiates Coverage on Knightscope (NASDAQ: KSCP) with a Buy Rating and $16 Price Target
Knightscope, Inc. (NASDAQ: KSCP), an innovator in robotics and artificial intelligence technologies focused on public safety, today announced that H.C. Wainwright & Co. has initiated coverage on the ...
bovnews6d
H.C. Wainwright Just Reiterated BigBear.ai Holdings Inc (BBAI) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 28.87% ...
Investing17d
H.C. Wainwright maintains buy on Akero stock
On Friday, H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing significant upside potential from the current trading price of $24.01.
Investing18d
H.C. Wainwright sets target on Aprea stock, Buy rating on clinical update
On Thursday, H.C. Wainwright reaffirmed its Buy rating and $20.00 stock price target for Aprea Therapeutics (NASDAQ:APRE), a biopharmaceutical company focused on developing and commercializing novel ...